Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11866496 Humanized anti-CD79B antibodies and immunoconjugates and methods of use

Patent 11866496 was granted and assigned to Genentech on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jagath Reddy Junutula0

Yvonne Chen0

Kristi Elkins0

Bing Zheng0

Andrew Polson0

Mark Dennis0

Date of Patent

January 9, 2024

0

Patent Application Number

172346950

Date Filed

April 19, 2021

0

Patent Citations

US Patent 7091186 None

0

US Patent 7097840 Methods of treatment using anti-ErbB antibody-maytansinoid conjugates

0

US Patent 7098305 Sustained release of microcrystalline peptide suspensions

0

US Patent 7098308 Pentapeptide compounds and uses related thereto

0

US Patent 7202346 Antibodies to non-shed Muc1 and Muc16, and uses thereof

0

US Patent 7276372 Antibodies against GPR64 and uses thereof

0

US Patent 7288248 Antibodies against cancer antigen TMEFF2 and uses thereof

0

US Patent 7303749 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents

0

...

Patent Primary Examiner

0

Patent abstract

The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11866496 Humanized anti-CD79B antibodies and immunoconjugates and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool